Electronic consent, or e-consent, is a method of obtaining informed consent through an electronic system rather than a paper form. It typically incorporates mul...
Continue reading
Clinical trials play a critical role in developing new treatments and therapies for Parkinson's disease, an age-related degenerative brain condition that causes...
Continue reading
Choosing a CRO partner affects every phase of a clinical trial. A mismatch in therapeutic expertise, regulatory experience, or service scope can introduce delay...
Continue reading
Over the past year, Sano and BenevolentAI have collaborated to demonstrate how an integrated, decentralized platform — combining patient recruitment, at-home ge...
Continue reading
In a this webinar, Patrick Short, CEO and co-founder of Sano Genetics, and Patti Engel, CEO of Engage Health, discussed how applying a “rare disease mindset” ca...
Continue reading
Precision medicine represents a fundamental shift in how therapies are developed and delivered. Rather than designing treatments for the average patient, it tak...
Continue reading
MASH (Metabolic dysfunction-associated steatohepatitis) is a chronic liver disease that has gained significant attention from the pharmaceutical industry and cl...
Continue reading
This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis....
Continue reading
This webinar was hosted by Sano Genetics' scientific advisor, Paul Wicks, and featured representatives from Genomics England as well as Sage Bionetworks. The di...
Continue reading
Decentralized and hybrid clinical trials hold significant promise for improving access and reducing patient burden. But implementing them introduces operational...
Continue reading